NOVEL THIENOPYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF
申请人:FIBROGEN, INC.
公开号:US20140221422A1
公开(公告)日:2014-08-07
The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF).
本发明涉及一种新型化合物,能够调节缺氧诱导因子(HIF)的稳定性和/或活性。
THIENOPYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF
申请人:FIBROGEN, INC.
公开号:EP1866318A2
公开(公告)日:2007-12-19
US8703795B2
申请人:——
公开号:US8703795B2
公开(公告)日:2014-04-22
US9000006B2
申请人:——
公开号:US9000006B2
公开(公告)日:2015-04-07
[EN] NOVEL THIENOPYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF<br/>[FR] NOUVEAUX COMPOSES A BASE DE THIENOPYRIDINE ET PROCEDES D'UTILISATION CORRESPONDANTS
申请人:FIBROGEN INC
公开号:WO2006094292A2
公开(公告)日:2006-09-08
[EN] The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF). [FR] La présente invention concerne de nouveaux composés capables de moduler la stabilité et/ou l'activité du facteur induit par l'hypoxie (HIF).